- Record: found
- Abstract: found
- Article: not found
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.
J P Gisbert
1 ,
M Romano ,
A G Gravina ,
P Solís-Muñoz ,
F Bermejo ,
J Molina-Infante ,
M Castro-Fernández ,
J Ortuño ,
A J Lucendo ,
M Herranz ,
I Modolell ,
F Del Castillo ,
J Gómez ,
J Barrio ,
B Velayos ,
B Gómez ,
J L Domínguez ,
A Miranda ,
M Martorano ,
A Algaba ,
M Pabón ,
T Angueira ,
L Fernández-Salazar ,
A Federico ,
A C Marín ,
A G McNicholl
Apr 2015
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The most commonly used second-line Helicobacter pylori eradication regimens are bismuth-containing quadruple therapy and levofloxacin-containing triple therapy, both offering suboptimal results. Combining bismuth and levofloxacin may enhance the efficacy of rescue eradication regimens.